About this Research Topic
Frontiers in Medicine is delighted to present the ‘Reviews in’ series of article collections.
Reviews in: Radiopharmaceuticals in Nuclear Medicine will publish high-quality review articles on key topics in the field. The goal of this series is to highlight recent advances within the field, whilst emphasizing important directions and new possibilities for future inquiries.
This collection welcomes full-length, mini or systematic review papers. New articles will be added to this collection as they are published.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Reviews in: Radiopharmaceuticals in Nuclear Medicine will publish high-quality review articles on key topics in the field. The goal of this series is to highlight recent advances within the field, whilst emphasizing important directions and new possibilities for future inquiries.
This collection welcomes full-length, mini or systematic review papers. New articles will be added to this collection as they are published.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: Radiopharmaceuticals, PET, Diagnostics, Radioligand, Radionuclide, Theranostics, #CollectionSeries
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
